Vanguard Group’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.76M Buy
1,551,449
+132,068
+9% +$713K ﹤0.01% 3144
2025
Q3
$5.96M Sell
1,419,381
-34,465
-2% -$122K ﹤0.01% 3216
2025
Q2
$4.17M Buy
1,453,846
+176,895
+14% +$467K ﹤0.01% 3268
2025
Q1
$3.45M Buy
1,276,951
+90,133
+8% +$338K ﹤0.01% 3305
2024
Q4
$2.8M Buy
1,186,818
+201,967
+21% +$537K ﹤0.01% 3461
2024
Q3
$2.33M Buy
984,851
+39,429
+4% +$86.8K ﹤0.01% 3509
2024
Q2
$1.84M Sell
945,422
-77,608
-8% -$264K ﹤0.01% 3584
2024
Q1
$6.58M Buy
1,023,030
+24,220
+2% +$220K ﹤0.01% 3181
2023
Q4
$14M Buy
998,810
+17,817
+2% +$281K ﹤0.01% 2770
2023
Q3
$24M Buy
980,993
+925,258
+1,660% +$23.4M ﹤0.01% 2477
2023
Q2
$1.82M Sell
55,735
-11,923
-18% -$335K ﹤0.01% 3694
2023
Q1
$1.88M Buy
+67,658
New +$1.1M ﹤0.01% 3698

Other funds holding GNLX

Vanguard Group's GNLX Position: Q4 2025 in Review

Vanguard Group increased its Genelux (GNLX) stake by 9.3% in Q4 2025, buying an estimated $713K and bringing the position to 1,551,449 shares worth $6.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

Vanguard Group first reported a position in GNLX in Q1 2023 and has held it in 12 quarters since. The position peaked at $24M in Q3 2023. 77 funds tracked by Wall St. Rank hold GNLX as of Q4 2025.

  • Vanguard Group held 1,551,449 shares of Genelux worth $6.76M as of Q4 2025.
  • Vanguard Group bought 132,068 Genelux shares in Q4 2025, an estimated $713K.
  • Genelux made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3144 holding.
  • Vanguard Group first reported a position in Genelux in Q1 2023 and has held it in 12 quarters since.
  • Vanguard Group's Genelux position peaked at $24M in Q3 2023.
  • 77 funds tracked by Wall St. Rank held Genelux as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.